GGrantIndex
Sort

50,496 grants matching lung cancer

Predictors of CVD among breast cancer survivors in an integrated health system

$618,653
Marilyn L Kwan · Kaiser Foundation Research Institute · R01 · FY2020 · CA

Early Detection and Mapping of Ischemia using Myocardial Elastography

$618,647
Elisa E Konofagou · Columbia University Health Sciences · R01 · FY2015 · EB

Translation of a Lung Cancer Palliative Care Intervention for Clinical Practice

$618,635
Betty R Ferrell · Beckman Research Institute/City Of Hope · R01 · FY2016 · NR

Detecting and locating cancer for patients with CT-detected lung nodules

$618,631
Xianghong Jasmine Zhou · University Of California Los Angeles · R01 · FY2024 · CA

Near infrared intraoperative molecular imaging of lung adenocarcinoma

$618,618
Sunil Singhal · University Of Pennsylvania · R01 · FY2020 · CA

Chronic Exposure to House Dust Mites: A New Risk Factor for Lung Cancer in Never Smokers

$618,586
Eyal Raz · University Of California, San Diego · U01 · FY2023 · CA

Adaptive Interventions for Smoking Cessation in Lung Cancer Screening Programs

$618,546
Anne Joseph · University Of Minnesota · R01 · FY2018 · CA

Credentialing next-generation human glioma models for precision therapeutics

$618,530
Christopher Ryan Miller · University Of Alabama At Birmingham · R01 · FY2022 · CA

Molecular Epidemiology of Secondary Lung Cancer

$618,513
Georgetown University · R01 · FY2004 · CA

Alternative MHCII Processing of Influenza Virus Proteins

$618,448
Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R01 · FY2016 · AI

Evaluating the implementation and impact of navigator-delivered ePRO home symptom monitoring and management

$618,409
Gabrielle Rocque · University Of Alabama At Birmingham · R01 · FY2023 · NR

Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis

$618,378
Kevin Keewoun Kim · University Of Michigan At Ann Arbor · R01 · FY2022 · HL

Pathogenesis and Treatment of Kaposiform Lymphangiomatosis

$618,343
Timothy David Le Cras · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · HL

Pathogenesis and Treatment of Kaposiform Lymphangiomatosis

$618,343
Timothy David Le Cras · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · HL

Pathogenesis and Treatment of Kaposiform Lymphangiomatosis

$618,343
Timothy David Le Cras · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · HL

RRM1 in the Management of Lung Cancer

$618,334
Gerold Bepler · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA

Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry

$618,327
Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA

Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer

$618,308
Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2025 · CA

Mechanics of Monolayer Migration

$618,297
Jeffrey J Fredberg · Harvard School Of Public Health · R01 · FY2012 · HL

PQ1: Identification and characterization of genetic alterations for the progression of pre-neoplastic lung lesions by using novel PDx models and deep sequencing

$618,295
David Sidransky · Johns Hopkins University · R01 · FY2019 · CA

Multi-scale model of microbial phenotype modulation by mucins

$618,287
Jason Papin · University Of Virginia · R01 · FY2021 · AI

Cancer Patient Safety Learning Laboratory (CaPSLL): Preventing Clinical Deterioration in Outpatients

$618,254
Matthew B Weinger · Vanderbilt University Medical Center · R18 · FY2018 · HS

Gene Methylation and Therapeutic Response in Lung Cancer

$618,196
Lovelace Biomedical &Environmental Res · R01 · FY2003 · CA

Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma

$618,054
Xiaoxin Chen · Coriell Institute For Medical Research · R01 · FY2025 · CA

Opening of the Blood Brain Barrier to Antitumor Agents

$617,969
Edward A Neuwelt · Oregon Health & Science University · R37 · FY2008 · NS